Published in Respir Res on April 08, 2005
Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2010) 1.97
Tgf-Beta isoform specific regulation of airway inflammation and remodelling in a murine model of asthma. PLoS One (2010) 1.07
Plasminogen is an important regulator in the pathogenesis of a murine model of asthma. Am J Respir Crit Care Med (2007) 0.89
Claudin-18 deficiency is associated with airway epithelial barrier dysfunction and asthma. J Allergy Clin Immunol (2016) 0.82
Airway deposition of nebulized gene delivery nanocomplexes monitored by radioimaging agents. Am J Respir Cell Mol Biol (2013) 0.81
Minicircle DNA Provides Enhanced and Prolonged Transgene Expression Following Airway Gene Transfer. Sci Rep (2016) 0.76
Detection and monitoring of localized matrix metalloproteinase upregulation in a murine model of asthma. Am J Physiol Lung Cell Mol Physiol (2014) 0.76
Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosis. Clin Sci (Lond) (2016) 0.75
Effects of the combined extracts of Herba Epimedii and Fructus Ligustrilucidi on airway remodeling in the asthmatic rats with the treatment of budesonide. BMC Complement Altern Med (2017) 0.75
Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol (1997) 6.42
Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J (1994) 3.92
Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J (1984) 3.81
Subepithelial fibrosis in the bronchi of asthmatics. Lancet (1989) 3.70
Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest (2003) 3.16
Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest (2004) 3.06
Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis (1989) 3.06
Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol (1997) 2.84
A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med (2002) 2.24
Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol (1990) 2.14
Mouse model of airway remodeling: strain differences. Am J Respir Crit Care Med (2003) 2.11
Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol (1999) 2.04
Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir Dis (1992) 2.02
The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway. Clin Exp Allergy (1997) 1.87
Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma. Clin Exp Allergy (1998) 1.80
Lung inflammation and epithelial changes in a murine model of atopic asthma. Am J Respir Cell Mol Biol (1996) 1.75
Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest (1997) 1.71
Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol (1998) 1.62
Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction. J Clin Invest (1996) 1.58
Histochemistry of Alcian blue. 3. The molecular biological basis of staining by Alcian blue 8GX and analogous phthalocyanins. Histochemie (1972) 1.55
Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids. Am J Respir Crit Care Med (2000) 1.49
Time course of inflammatory and remodeling events in a murine model of asthma: effect of steroid treatment. Am J Physiol Lung Cell Mol Physiol (2000) 1.49
Proteoglycan histochemistry--a valuable tool for connective tissue biochemists. Coll Relat Res (1985) 1.49
Modeling allergic asthma in mice: pitfalls and opportunities. Am J Respir Cell Mol Biol (2002) 1.47
Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease. Am J Respir Crit Care Med (1998) 1.47
TGF-beta1 causes airway fibrosis and increased collagen I and III mRNA in mice. Thorax (2003) 1.45
Enhanced proteoglycan deposition in the airway wall of atopic asthmatics. Am J Respir Crit Care Med (1999) 1.43
Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med (1997) 1.39
On the mechanism of mucosal folding in normal and asthmatic airways. J Appl Physiol (1985) (1997) 1.38
Role of interleukin-13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthma. Clin Exp Allergy (2002) 1.37
Airway responsiveness and bronchial-wall thickness in asthma with or without fixed airflow obstruction. Am J Respir Crit Care Med (1995) 1.37
The effect of allergen-induced airway inflammation on airway remodeling in a murine model of allergic asthma. Inflamm Res (2001) 1.25
Mast cells play a partial role in allergen-induced subepithelial fibrosis in a murine model of allergic asthma. Clin Exp Allergy (2003) 1.22
Biochemical and histological changes in pulmonary fibrosis induced in rabbits with intratracheal bleomycin. Eur J Clin Invest (1981) 1.15
Prolonged allergen exposure induces structural airway changes in sensitized rats. Am J Respir Crit Care Med (2000) 1.14
Prolonged antigen exposure ameliorates airway inflammation but not remodeling in a mouse model of bronchial asthma. Int Arch Allergy Immunol (2001) 1.09
The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7. J Biol Chem (2000) 1.08
Is asthma a fibrotic disease? Chest (1995) 1.06
Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med (1997) 1.06
Cytokine, chemokine and chemokine receptor mRNA expression in different strains of normal mice: implications for establishment of a Th1/Th2 bias. J Neuroimmunol (1999) 1.03
Correlation between airway responsiveness and proteoglycan production by bronchial fibroblasts from normal and asthmatic subjects. Int J Biochem Cell Biol (2002) 1.03
IL-5 deficiency abolishes aspects of airway remodelling in a murine model of lung inflammation. Clin Exp Allergy (2001) 1.02
The functional consequences of airway remodeling in asthma. Monaldi Arch Chest Dis (1997) 1.01
Mechanisms preventing allergen-induced airways hyperreactivity: role of tolerance and immune deviation. J Allergy Clin Immunol (2000) 0.98
Pathological changes according to the severity of asthma. Clin Exp Allergy (1996) 0.96
Structure and function in extracellular matrices depend on interactions between anionic glycosaminoglycans. Pathol Biol (Paris) (2001) 0.94
Decorin, biglycan and their endocytosis receptor in rat renal cortex. Kidney Int (1998) 0.94
Murine model of chronic human asthma. Immunol Cell Biol (2001) 0.93
Co-localization of immunoreactive transforming growth factor-beta 1 and decorin in bronchial biopsies from asthmatic and normal subjects. J Pathol (1998) 0.86
Effects of lung volume, bronchoconstriction, and cigarette smoke on morphometric airway dimensions. J Appl Physiol (1985) (1988) 0.85
The involvement of matrix metalloproteinases in basement membrane injury in a murine model of acute allergic airway inflammation. Clin Exp Allergy (2002) 0.82
Airway remodeling of murine chronic antigen exposure model. J Asthma (2003) 0.79
Identification of decorin proteoglycan in bovine tracheal serous cells in culture and localization of decorin mRNA in situ. Eur J Cell Biol (1994) 0.76
Detection of chondroitin sulfates and decorin in developing fetal and neonatal rat lung. Am J Physiol Lung Cell Mol Physiol (2002) 0.76
Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol (2002) 2.84
Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med (2002) 2.51
Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J Clin Invest (2006) 2.40
Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am J Pathol (2003) 2.14
Pulmonary fibrosis: searching for model answers. Am J Respir Cell Mol Biol (2005) 2.05
Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2010) 1.97
Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. J Clin Invest (2009) 1.96
Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E(2) production. Am J Pathol (2004) 1.56
Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis. Am J Pathol (2005) 1.53
Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q). Am J Pathol (2009) 1.50
Serum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae. PLoS Pathog (2007) 1.46
Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol (2003) 1.46
Neutrophil elastase: mediator of extracellular matrix destruction and accumulation. Proc Am Thorac Soc (2006) 1.35
Fibroblasts isolated from normal lungs and those with idiopathic pulmonary fibrosis differ in interleukin-6/gp130-mediated cell signaling and proliferation. Am J Pathol (2003) 1.31
Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs. Am J Respir Cell Mol Biol (2003) 1.27
TGF-beta: its role in asthma and therapeutic potential. Curr Drug Targets (2006) 1.27
Mice lacking neutrophil elastase are resistant to bleomycin-induced pulmonary fibrosis. Am J Pathol (2007) 1.13
Differential roles of extracellular signal-regulated kinase 1/2 and p38MAPK in mechanical load-induced procollagen alpha1(I) gene expression in cardiac fibroblasts. Cardiovasc Res (2004) 1.09
Tgf-Beta isoform specific regulation of airway inflammation and remodelling in a murine model of asthma. PLoS One (2010) 1.07
Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis. EMBO Mol Med (2012) 1.07
Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis. Am J Respir Crit Care Med (2008) 1.06
Evidence for incorporation of free-floating mesothelial cells as a mechanism of serosal healing. J Cell Sci (2002) 1.00
Factor Xa stimulates fibroblast procollagen production, proliferation, and calcium signaling via PAR1 activation. Exp Cell Res (2004) 0.99
Escape from the matrix: multiple mechanisms for fibroblast activation in pulmonary fibrosis. Proc Am Thorac Soc (2008) 0.99
Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis. Int J Cancer (2006) 0.98
Oncostatin M stimulates proliferation, induces collagen production and inhibits apoptosis of human lung fibroblasts. Br J Pharmacol (2002) 0.96
STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP/IPF. Am J Pathol (2012) 0.94
Genetic polymorphisms associated with susceptibility and outcome in ARDS. Chest (2002) 0.94
A receptor-targeted nanocomplex vector system optimized for respiratory gene transfer. Mol Ther (2008) 0.93
Absence of proteinase-activated receptor-1 signaling in mice confers protection from fMLP-induced goblet cell metaplasia. Am J Respir Cell Mol Biol (2009) 0.92
Shooting for PARs in lung diseases. Curr Opin Pharmacol (2004) 0.91
Evaluation of a porcine model for pulmonary gene transfer using a novel synthetic vector. J Gene Med (2002) 0.90
Characterization of a new mouse model of empyema and the mechanisms of pleural invasion by Streptococcus pneumoniae. Am J Respir Cell Mol Biol (2011) 0.89
BARD1: an independent predictor of survival in non-small cell lung cancer. Int J Cancer (2011) 0.88
Functional prostaglandin-endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis. Am J Respir Crit Care Med (2006) 0.87
Efficient transfection of non-proliferating human airway epithelial cells with a synthetic vector system. J Gene Med (2004) 0.84
Nebulisation of receptor-targeted nanocomplexes for gene delivery to the airway epithelium. PLoS One (2011) 0.84
Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis. Eur Respir J (2013) 0.83
Analysis and optimization of the cationic lipid component of a lipid/peptide vector formulation for enhanced transfection in vitro and in vivo. J Liposome Res (2006) 0.81
Airway deposition of nebulized gene delivery nanocomplexes monitored by radioimaging agents. Am J Respir Cell Mol Biol (2013) 0.81
Liver growth, development and disease--new research revealing new horizons. Int J Biochem Cell Biol (2010) 0.80
Small heat shock proteins: molecular protectors against the disease. Int J Biochem Cell Biol (2012) 0.80
Pediatric lung disease: from proteinases to pulmonary fibrosis. Pediatr Pulmonol (2005) 0.79
The quest for the initial lesion in idiopathic pulmonary fibrosis: gene expression differences in IPF fibroblasts. Am J Respir Cell Mol Biol (2010) 0.78
An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis. Am J Respir Cell Mol Biol (2017) 0.77
No bit PARt for PAR-1. Am J Respir Cell Mol Biol (2005) 0.77
Epigenetics and human disease. Int J Biochem Cell Biol (2008) 0.77
Diabetes: new challenges for the control of disease globalisation. Int J Biochem Cell Biol (2006) 0.75
Bioenergetic dysfunction in disease. Int J Biochem Cell Biol (2012) 0.75
A case of scientific fraud. Int J Biochem Cell Biol (2004) 0.75
Muscle atrophy: from molecular pathways to clinical therapy. Int J Biochem Cell Biol (2013) 0.75
Editorial: A case of scientific fraud. Electrophoresis (2004) 0.75
Biophysical characterization of an integrin-targeted non-viral vector. Med Sci Monit (2003) 0.75
Targeting metabolic pathways for cancer therapy. Int J Biochem Cell Biol (2011) 0.75
Organelles in Focus launch. Int J Biochem Cell Biol (2011) 0.75
Special Issue on HIV. Int J Biochem Cell Biol (2004) 0.75
Proteases and antiproteases in immune defense, tissue homeostasis and development. Int J Biochem Cell Biol (2008) 0.75
Mechanisms of inflammation. Int J Biochem Cell Biol (2010) 0.75
Mitochondria matter: new concepts of dynamics and roles in pathophysiology. Int J Biochem Cell Biol (2009) 0.75
Quantitative assessment of subepithelial collagen deposition in the airways of mice following ovalbumin sensitization and intratracheal challenge. Chest (2003) 0.75